Published in N Engl J Med on November 03, 2005
Structure, function and diversity of the healthy human microbiome. Nature (2012) 30.40
Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A (2010) 12.39
Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods (2012) 8.37
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl Environ Microbiol (2008) 4.58
Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol (2007) 3.10
Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One (2008) 3.01
Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One (2012) 2.79
Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol (2012) 2.75
Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol (2008) 2.73
Deep sequencing of the vaginal microbiota of women with HIV. PLoS One (2010) 2.59
The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis (2009) 2.56
Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology (2009) 2.55
Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio (2010) 2.53
The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 2.41
Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS One (2012) 2.34
DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo. J Infect Dis (2013) 2.29
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol (2009) 2.29
The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome (2014) 2.24
The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19
Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS (2010) 2.17
The effects of circumcision on the penis microbiome. PLoS One (2010) 2.15
Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol (2011) 2.11
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med (2012) 2.06
Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol (2007) 2.06
Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics (2010) 2.04
Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS One (2010) 2.02
Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis (2010) 2.02
Genomic approaches to studying the human microbiota. Nature (2012) 2.00
Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J Infect Dis (2008) 1.99
Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol (2012) 1.94
Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J Bacteriol (2008) 1.93
Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect (2008) 1.83
Comparison of self-collected and physician-collected vaginal swabs for microbiome analysis. J Clin Microbiol (2010) 1.82
Global report on preterm birth and stillbirth (2 of 7): discovery science. BMC Pregnancy Childbirth (2010) 1.79
Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A (2015) 1.79
Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol (2010) 1.74
Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis (2012) 1.73
Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol (2010) 1.69
A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol (2008) 1.63
Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr (2009) 1.61
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59
Genomic determinants of sporulation in Bacilli and Clostridia: towards the minimal set of sporulation-specific genes. Environ Microbiol (2012) 1.59
The vaginal bacterial communities of Japanese women resemble those of women in other racial groups. FEMS Immunol Med Microbiol (2009) 1.59
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59
Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis (2013) 1.56
Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect Dis (2007) 1.51
Heterogeneity of vaginal microbial communities within individuals. J Clin Microbiol (2009) 1.50
Species-level classification of the vaginal microbiome. BMC Genomics (2012) 1.49
Biogeography of the ecosystems of the healthy human body. Genome Biol (2013) 1.48
Investigating the biological and clinical significance of human dysbioses. Trends Microbiol (2011) 1.48
Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol (2010) 1.45
Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One (2009) 1.44
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest (2011) 1.44
Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect Dis Obstet Gynecol (2010) 1.43
The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One (2014) 1.43
High-throughput sequencing technologies. Mol Cell (2015) 1.42
Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Microbiology (2009) 1.35
The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term. Microbiome (2014) 1.35
Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One (2012) 1.34
The complexity of microbial diversity in bacterial vaginosis. N Engl J Med (2005) 1.33
Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis (2006) 1.30
At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci U S A (2010) 1.30
Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. AIDS Res Hum Retroviruses (2010) 1.29
Prevalence and abundance of uncultivated Megasphaera-like bacteria in the human vaginal environment. Appl Environ Microbiol (2008) 1.29
Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome (2013) 1.28
Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle. Proc Natl Acad Sci U S A (2014) 1.26
The effects of commensal bacteria on innate immune responses in the female genital tract. Am J Reprod Immunol (2010) 1.26
The human microbiome: from symbiosis to pathogenesis. Annu Rev Med (2013) 1.25
Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One (2010) 1.24
Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One (2013) 1.21
Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause (2014) 1.21
Influence of infection during pregnancy on fetal development. Reproduction (2013) 1.20
Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol (2010) 1.20
Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology (2014) 1.20
Understanding vaginal microbiome complexity from an ecological perspective. Transl Res (2012) 1.19
Newly identified pathogens associated with periodontitis: a systematic review. J Dent Res (2014) 1.19
Metabolic signatures of bacterial vaginosis. MBio (2015) 1.18
Gardnerella vaginalis does not always cause bacterial vaginosis. J Infect Dis (2014) 1.17
Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol (2007) 1.17
Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol (2007) 1.16
Multiplex detection of bacteria associated with normal microbiota and with bacterial vaginosis in vaginal swabs by use of oligonucleotide-coupled fluorescent microspheres. J Clin Microbiol (2009) 1.16
Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women. PLoS One (2012) 1.16
Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS One (2011) 1.15
Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J (2014) 1.14
An in vitro biofilm model system maintaining a highly reproducible species and metabolic diversity approaching that of the human oral microbiome. Microbiome (2013) 1.13
The complex vaginal flora of West African women with bacterial vaginosis. PLoS One (2011) 1.13
Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women. AIDS Res Hum Retroviruses (2012) 1.11
The microbiota of the vagina and its influence on women's health and disease. Am J Med Sci (2012) 1.11
Twice-daily application of HIV microbicides alter the vaginal microbiota. MBio (2012) 1.11
Exploration of bacterial community classes in major human habitats. Genome Biol (2014) 1.11
Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study. Eur J Clin Microbiol Infect Dis (2008) 1.10
Research gaps in defining the biological link between HIV risk and hormonal contraception. Am J Reprod Immunol (2014) 1.08
A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women. Sex Transm Dis (2008) 1.08
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol (2015) 1.07
More than meets the eye: associations of vaginal bacteria with gram stain morphotypes using molecular phylogenetic analysis. PLoS One (2013) 1.07
Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria. BMC Infect Dis (2009) 1.07
Quantitative survival of aerobic and anaerobic microorganisms in Port-A-Cul and Copan transport systems. J Clin Microbiol (2008) 1.07
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015) 4.33
Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol (2007) 3.10
Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One (2012) 2.79
Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol (2008) 2.73
Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One (2010) 2.62
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol (2009) 2.29
A persistent(ly) enigmatic ecological mystery: bacterial vaginosis. J Infect Dis (2006) 1.83
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59
Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR. J Clin Microbiol (2005) 1.41
Variations in Clinical Presentation of Ocular Syphilis: Case Series Reported From a Growing Epidemic in the United States. Sex Transm Dis (2016) 1.38
Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. PLoS One (2011) 1.28
Barriers to Bacterial Sexually Transmitted Infection Testing of HIV-Infected Men Who Have Sex With Men Engaged in HIV Primary Care. Sex Transm Dis (2015) 1.20
Molecular methodology in determining vaginal flora in health and disease: its time has come. Curr Infect Dis Rep (2005) 1.14
Risks for acquisition of bacterial vaginosis among women who report sex with women: a cohort study. PLoS One (2010) 1.08
Population-based outreach for Chlamydia screening in men: results from a randomized trial. Sex Transm Dis (2007) 1.07
More than meets the eye: associations of vaginal bacteria with gram stain morphotypes using molecular phylogenetic analysis. PLoS One (2013) 1.07
The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women. Sex Transm Dis (2008) 1.01
Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J Infect Dis (2012) 1.00
Chlamydia trachomatis infection among women reporting sexual activity with women screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005. Am J Public Health (2010) 0.99
Re-evaluating selective screening criteria for chlamydial infection among women in the U S Pacific Northwest. Sex Transm Dis (2004) 0.94
Chlamydia trachomatis infection in asymptomatic men. Am J Prev Med (2003) 0.93
Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis (2012) 0.92
The clinical and economic consequences of screening young men for genital chlamydial infection. Sex Transm Dis (2003) 0.91
Sexually transmitted infections among women who have sex with women. Clin Infect Dis (2011) 0.90
Dangerous assumptions: lesbians and sexual death. Sex Transm Dis (2005) 0.89
Vaginal biofilms and bacterial vaginosis: of mice and women. J Infect Dis (2013) 0.87
Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002. Sex Transm Dis (2006) 0.86
Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate. J Acquir Immune Defic Syndr (2016) 0.85
The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature. Sex Transm Dis (2008) 0.85
Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing. J Clin Microbiol (2005) 0.84
Bacterial vaginosis-associated bacteria in men: association of Leptotrichia/Sneathia spp. with nongonococcal urethritis. Sex Transm Dis (2013) 0.84
Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial. J Acquir Immune Defic Syndr (2015) 0.83
An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women. J Acquir Immune Defic Syndr (2016) 0.82
Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and Gardnerella vaginalis. Sex Transm Dis (2011) 0.82
Selective testing criteria for gonorrhea among young women screened for Chlamydial infection: contribution of race and geographic prevalence. J Infect Dis (2007) 0.81
Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis. J Acquir Immune Defic Syndr (2016) 0.80
Molecular identification of an invasive gingival bacterial community. Clin Infect Dis (2005) 0.80
Even NHANES evolves: Some surprising findings about women who have sex with women. Sex Transm Dis (2010) 0.78
Factors associated with bone mineral density in healthy African women. Arch Osteoporos (2015) 0.77
Elusive aetiology of bacterial vaginosis. Do lesbians have a clue? Sex Transm Infect (2007) 0.75
Implementation and Operational Research: Effectiveness and Patient Acceptability of a Sexually Transmitted Infection Self-Testing Program in an HIV Care Setting. J Acquir Immune Defic Syndr (2016) 0.75
Advancing Care for Lesbian, Gay, Bisexual, and Transgender Persons: Enough Already? Ann Intern Med (2015) 0.75
Correlates of sexually transmitted infections in young women. J Infect Dis (2007) 0.75
Expanding the spectrum of pathogens in urethritis: implications for presumptive therapy? Clin Infect Dis (2007) 0.75
Editorial commentary: Sexual networks, sex hormones, and recurrent bacterial vaginosis: not such strange bedfellows. Clin Infect Dis (2012) 0.75
Screening and management of genital chlamydial infections. Infect Dis Clin North Am (2013) 0.75
Superficial hepatic capsular lesions in a systemically ill young woman. Sex Transm Dis (2007) 0.75
American Sexually Transmitted Diseases Association and the Thomas Parran Award: past, present, and future. Sex Transm Dis (2013) 0.75